The high-performance metal powder developer secured $21.1m in a round led by The Heritage Group's investment subsidiary, which provided $7m.

CAS Shanghai Institutes for Biological Sciences spinout Aptbio secured funding to enhance its mass spectrometry drug screening business.

The Parkinson's disease therapy developer completed a series A round featuring QB3-aligned Mission Bay Capital.

Dumac contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

EPFL spinout Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

Guru has closed a $30m series C round backed by returning investor Slack, bringing the sales advice software developer’s total funding to $68m.

Lunaphore has received $2m in a series C extension provided by Swiss Entrepreneurs Fund, adding to an initial $23.6m tranche led by PHC Holdings three months ago.

The valve calcification treatment developer raised the cash from Sofinnova Partners and existing backers that may include Clal Biotechnology Industries.

Return investor SBCVC contributed to a round that took the total raised by the cancer screening system developer past the $130m mark.

SAP.io returned to help marketing analytics software developer Adverity boost its total funding to $50m, with the latest cash to go to recruitment and R&D.